Evidence map›Paper›PMID 41739942›Full record

ArticleScience advances2026

Chronic intermittent hypoxia reshapes circadian metabolic architecture in a model of sleep apnea.

Emilie Montellier, Guillaume Vial, Sophie Bouyon, Kousha Changizi Ashtiani, Sherif Abdelkarim, Emeline Lemarie, Antoine Boutin, Kenichiro Kinouchi, Pierre Baldi, Jean-Louis Pépin and 1 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CircadiOmics: bioinformatics platform for circadian rhythms.Bioinformatics (Oxford, England) · 2026
    Article
  2. bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emilie MontellierUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0001-5069-3536
Guillaume VialUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0002-7333-8526
Sophie BouyonUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0002-7868-1884
Kousha Changizi AshtianiDepartment of Computer Science, University of California, Irvine, CA, USA.ORCID 0009-0005-9233-5899
Sherif AbdelkarimDepartment of Computer Science, University of California, Irvine, CA, USA.ORCID 0000-0002-7456-6133
Emeline LemarieUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0009-0000-3341-5665
Antoine BoutinUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0001-5269-2035
Kenichiro KinouchiDivision of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-4743-2583
Pierre BaldiDepartment of Computer Science, University of California, Irvine, CA, USA.ORCID 0000-0001-8752-4664
Jean-Louis PépinUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0003-3832-2358
Jonathan GaucherUniv. Grenoble Alpes (UGA), Inserm (French National Institute of Health and Medical Research) Unit 1300, Hypoxia and Physiopathology Laboratory (HP2), Grenoble, France.ORCID 0000-0002-1654-8009

Funding

Bioinformatics Tools for Circadian BiologyR01GM123558 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Pierre Baldi · 2017 to 2026
$2.4M
NIGMS NIH HHS R01 GM123558
6 · The paper itself

Abstract

Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (IH) during sleep, is increasingly recognized as a driver of metabolic dysfunction. However, its impact on circadian metabolic regulation remains poorly understood. Here, we investigated how chronic IH reshapes 24-hour hepatic and systemic metabolic programs in a mouse model mimicking OSA-associated chronic hypoxia. Through integrated circadian transcriptomic, metabolomic, and physiological 24-hour profiling, we show that 4 weeks of rest phase-restricted IH reprograms hepatic and systemic metabolism in a time-specific manner. This reorganization involves the coordinated circadian regulation of glucose, lipid, and redox pathways, with a shift away from oxidative metabolism toward oxygen-sparing processes such as gluconeogenesis, glycogen turnover, and lipid mobilization. These changes align with the hypoxic phase exposure and coincide with reshaped hepatic metabolite oscillations and systemic autonomic rhythms, supporting a functional adaptation to intermittent oxygen availability. Mechanistically, we identify the cAMP-CREB1 pathway as a driver of circadian transcriptional remodeling in the liver and a central integrator of IH-dependent adrenergic stress. Our findings establish chronic IH as a potent metabolic zeitgeber that rewires hepatic transcriptional and metabolic programs, revealing a circadian dimension to the metabolic consequences of sleep-disordered breathing.

Indexed as

Circadian RhythmHypoxiaSleep Apnea, ObstructiveSleep Apnea SyndromesAnimalsCyclic AMPCyclic AMP Response Element-Binding ProteinDisease Models, AnimalLiverMaleMetabolic ReprogrammingMiceCreb1 protein, mouseCyclic AMPCyclic AMP Response Element-Binding Protein

Identifiers

PMID41739942
PMCPMC12935056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.